Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Wall Street skids on Omicron worry, obstacle to Biden social-spending package

Published 12/20/2021, 06:37 AM
Updated 12/20/2021, 08:36 PM
© Reuters. FILE PHOTO: Traders work on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., December 3, 2021.  REUTERS/Brendan McDermid

By Lewis Krauskopf, Shreyashi Sanyal and Anisha Sircar

(Reuters) - Wall Street's main indexes dropped more than 1% on Monday as investors worried about the Omicron COVID-19 variant potentially undercutting the economic rebound and a critical setback to President Joe Biden's social-spending bill.

The financials and materials sectors fell most among S&P 500 sectors, while declines in mega-cap tech and tech-related stocks also dragged.

Coronavirus cases surged in New York City and around the United States over the weekend, dashing hopes for a more normal holiday season. Britain's leader said he would take more steps to slow the spread of Omicron if needed, after the Netherlands began a fourth lockdown and as other European nations considered restrictions.

"I think (the stock market) is down over COVID fears and how those fears may extend the continuing supply-chain problems and how that will impact profits ... for companies,” Chuck Carlson, chief executive officer at Horizon Investment Services in Hammond, Indiana.

The Dow Jones Industrial Average fell 433.28 points, or 1.23%, to 34,932.16, the S&P 500 lost 52.62 points, or 1.14%, to 4,568.02 and the Nasdaq Composite dropped 188.74 points, or 1.24%, to 14,980.94.

Financials fell 1.9% and materials dropped 1.8%. Microsoft (NASDAQ:MSFT) and Tesla (NASDAQ:TSLA) were the biggest individual weights on the S&P 500, falling 1.2% and 3.5% respectively.

The indexes finished above their session lows, but the benchmark S&P 500 ended below its 50-day moving average, a key technical level.

In a further knock to market sentiment, U.S. Senator Joe Manchin said on Sunday he would not support Biden's $1.75 trillion domestic investment bill Build Back Better, dealing it a potentially fatal blow.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

After Manchin's comments, Goldman Sachs (NYSE:GS) trimmed its quarterly U.S. GDP forecasts for 2022.

The developments came as the Federal Reserve decided last week to end its pandemic-era stimulus faster, with the central bank signaling at least three quarter-percentage-point interest rate hikes by the end of 2022.

Investors have taken a more defensive stance this month, with sectors such as consumer staples and utilities rising most. Those two groups ended Monday's session with slim gains, the only sectors in positive territory.

The S&P 500 remains up 21.6% so far in 2021.

“Given the strength of the market so far this year, in some ways you could see investors take some profits and look for greater clarity in the new year,” said Michael Arone, chief investment strategist at State Street (NYSE:STT) Global Advisors.

In company news, Oracle Corp (NYSE:ORCL) shares fell 5.2% after the business software maker said it would buy electronic medical records company Cerner Corp (NASDAQ:CERN) for $28.3 billion.

Declining issues outnumbered advancing ones on the NYSE by a 4.38-to-1 ratio; on Nasdaq, a 2.70-to-1 ratio favored decliners.

The S&P 500 posted two new 52-week highs and 11 new lows; the Nasdaq Composite recorded 13 new highs and 346 new lows.

About 11.4 billion shares changed hands in U.S. exchanges, below the 12 billion daily average over the last 20 sessions.

Latest comments

vaccine is a trap?
Glad the headlines are starting to acknowledge that it’s government response that people fear more than the virus.
OH MY GAWD, sell everything!!! Common cold variant is here! Entire world going on lockdown for fatigue and sore throat symptoms!
Here we go with the armchair scientists
And these mild symptoms are even for non vaccinated.
I’m not an armchair scientist, this is what the head of medicine in South Africa said. That doctors report the symptoms of omicron are “mild” compared to delta and consist of fatigue and sore throats. I.E. the common cold variant of COVID.
And don't forget Munchin...
Mnuchin did everyone a huge favor.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.